CPHA Canvax

From 2021 to 2022, global coverage with the first dose of diphtheria-tetanus-pertussis–containing vaccine increased from 86% to 89%, and with the first dose of measles-containing vaccine from 81% to 84%, but neither returned to 2019 prepandemic coverage levels of 90% and 86%, respectively. Coverage recovery was unevenly distributed across regions and countries and slower among low-income countries.

Rating See Comments Ratings


Outbreaks and Pandemics,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Vaccine Preventable Diseases,Communicable Diseases,Non-communicable Disease,Tetanus (Lockjaw),Diphtheria,Pertussis (Whooping Cough),Poliomyelitis (Polio),Measles Outbreaks and Pandemics
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Diseases
Communicable Diseases
Non-communicable Disease
Tetanus (Lockjaw)
Pertussis (Whooping Cough)
Poliomyelitis (Polio)


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.